Richard A. Fair - Net Worth and Insider Trading
Richard A. Fair Net Worth
The estimated net worth of Richard A. Fair is at least $883 dollars as of 2024-05-02. Richard A. Fair is the President and CEO of Bellicum Pharmaceuticals Inc and owns about 11,813 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $883. Details can be seen in Richard A. Fair's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A. Fair has not made any transactions after 2020-03-17 and currently still holds the listed stock(s).
Transaction Summary of Richard A. Fair
Richard A. Fair Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard A. Fair owns 2 companies in total, including Clovis Oncology Inc (CLVSQ) , and Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of Richard A. Fair’s form 4 insider trades.
Insider Ownership Summary of Richard A. Fair
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLVSQ | Clovis Oncology Inc | 2018-10-11 | director |
| BLCM | Bellicum Pharmaceuticals Inc | 2020-03-17 | director & President and CEO |
Richard A. Fair Latest Holdings Summary
Richard A. Fair currently owns a total of 1 stock. Richard A. Fair owns 11,813 shares of Bellicum Pharmaceuticals Inc (BLCM) as of March 17, 2020, with a value of $883.
Latest Holdings of Richard A. Fair
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2020-03-17 | 11,813 | 0.07 | 883 |
Holding Weightings of Richard A. Fair
Richard A. Fair Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard A. Fair has made a total of 3 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Bellicum Pharmaceuticals Inc is the acquisition of 5,000 shares on March 17, 2020, which cost Richard A. Fair around $20,000.
Insider Trading History of Richard A. Fair
- 1
Richard A. Fair Trading Performance
GuruFocus tracks the stock performance after each of Richard A. Fair's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard A. Fair is 27.28%. GuruFocus also compares Richard A. Fair's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard A. Fair within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard A. Fair's insider trading performs compared to the benchmark.
Performance of Richard A. Fair
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.67 | | | | | |
| Relative Return to S&P 500(%) | 14.81 | | | | | |
Richard A. Fair Ownership Network
Richard A. Fair Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
Richard A. Fair is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
Richard A. Fair Mailing Address
Above is the net worth, insider trading, and ownership report for Richard A. Fair. You might contact Richard A. Fair via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
